Optometrists in Gresham, OR Accepting Medicare
27 Optometrists found. Showing 21 - 27
 Dr. Krista Ann Tomlinson Coontz, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 970 Nw Eastman Pkwy, Gresham, OR 97030 Phone: 503-465-1896 Fax: 503-465-1023 |
 Dan Caldwell, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 125 Nw Miller Ave, Gresham, OR 97030 Phone: 503-665-5415 Fax: 503-492-2313 |
Dr. Mel G Macphee, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1201 Se 223rd Ave Ste 160, Gresham, OR 97030 Phone: 503-492-2020 Fax: 503-465-6825 |
Dr. Ronald L Kerns, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 22400 Se Stark St, Gresham, OR 97030 Phone: 503-665-0621 |
 Pacific Eye Group, Pc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 970 Nw Eastman Pkwy, Gresham, OR 97030 Phone: 503-666-7460 Fax: 503-667-8006 |
Kat Eye Corporation Optometrist Medicare: Medicare Enrolled Practice Location: 1201 Se 223rd Ave Ste 160, Gresham, OR 97030 Phone: 503-492-2020 |
Mark A. George, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 22640 Se Stark St, Gresham, OR 97030 Phone: 503-667-0441 Fax: 503-666-6718 |
News Archive
Sun Valley Juice ordered by FDA to cease all operations
The U.S. Food and Drug Administration has ordered Sun Valley Juice Company of Ketchum, Idaho, to stop receiving, processing, preparing, packing, holding, and distributing juice until the agency determines that the company is in compliance with laws and regulations applicable to producing food that is safe.
Many young adults couldn't afford needed health care: New Commonwealth Fund report
Young adults ages 19-29 are struggling to get the health care they need more than almost any other age group, demonstrating the need for Affordable Care Act provisions, some already in place, that will expand health insurance and make it more affordable, according to a new Commonwealth Fund report.
LigoCyte to enroll 98 subjects in first clinical trial for bivalent IM norovirus vaccine
LigoCyte Pharmaceuticals, Inc., a private, clinical-stage biopharmaceuticals company focused on the development of innovative vaccine products, announced today that it has initiated the first clinical trial for its bivalent intramuscular (IM) norovirus vaccine candidate, marking the fourth human clinical trial in the Company's norovirus virus-like particle (VLP) vaccine program.
Hooper Holmes' revenues for fourth-quarter of 2009 decline by 5%
Hooper Holmes today announced financial results for the fourth quarter and year ended December 31, 2009.
Senate could vote today on tougher tobacco legislation
The Senate could vote today on tougher tobacco laws that would give the Food and Drug Adminstration power to regulate tobacco.
› Verified 2 days ago
- 1
- 2(current)
Chiropractors
Physical Therapists
Occupational Therapists
Speech-Language Pathologists
Optometrists
Podiatrists
Audiologists